ORFADIN 4 mg/ml SUSPENSION ORAL
ORFADIN 4 mg/ml SUSPENSION ORAL
Commercialized
Register Number
104303005
Prescription Type
Uso Hospitalario
Authorization Date
Jul 26, 2015
Dosage Form
SUSPENSIÓN ORAL
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number104303005
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
NITISINONAActive
Quantity: 4,0 mg
Name: NITISINONA
ATC CLASSIFICATION (3)
A16A
A16AX
A16AX04